ArticleNature communications2022
Hyperpolarised
Erratum issuedOpen access · goldAbstract read
In one paragraph
Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 46 papers.
0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed, 60 citations in OpenAlex.
- Hyperpolarized MRI in Oncology-A Review of Clinical Studies and Evaluation of Preclinical Liver Studies.NMR in biomedicine · 2026Review
- MR-based techniques for imaging prostate cancer metabolism: current status and future perspectives.Abdominal radiology (New York) · 2026Review
- Imaging the hallmarks of cancer.Nature reviews. Cancer · 2026Review
- Label-free navigation system for grading prostate tumour malignancy in situ via tissue pH and prostate-specific antigen activity.Nature biomedical engineering · 2026Article
- Quantitative Imaging of Pyruvate Metabolism in a Patient With Anaplastic Thyroid Cancer.Magnetic resonance in medicine · 2026Article
- Ultra-low fieldCommunications chemistry · 2026Article
- Technologies and Strategies for Metabolic and Molecular Imaging With Hyperpolarized MRI.Journal of magnetic resonance imaging : JMRI · 2026Review
- Preclinical Applications of Magnetic Resonance Imaging in Oncology.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026Review
- Current state of the art of new prostate MRI technologies and potential future developments.BJR open · 2026Review
- Scalable Hyperpolarized MRI Enabled by Ace-SABRE of [1-Angewandte Chemie (International ed. in English) · 2025Article
- Multivariate Framework of Metabolism in Advanced Prostate Cancer Using Whole Abdominal and Pelvic HyperpolarizedCancers · 2025Article
- Assessment of early response to neoadjuvant chemotherapy in multi-site high-grade serous ovarian cancer using hyperpolarized-EJNMMI research · 2025Article
- Metabolic imaging distinguishes ovarian cancer subtypes and detects their early and variable responses to treatment.Oncogene · 2025Article
- Lactate and lactylation in cancer.Signal transduction and targeted therapy · 2025Review
- K-Means Clustering of HyperpolarisedCancers · 2025Article
- Quo Vadis HyperpolarizedZeitschrift fur medizinische Physik · 2025Review
- Hyperpolarized-MRI in Hypertrophic Cardiomyopathy: A Narrative Review.Clinical Medicine Insights. Cardiology · 2025Review
- Article
- Metabolic imaging across scales reveals distinct prostate cancer phenotypes.Nature communications · 2024Article
- Long-lived enhanced magnetization-A practical metabolic MRI contrast material.Science advances · 2024Article
Corrections and comments
- Commented on byHP2022
- Erratum issued
Authors and funding
22 authors at 5 institutions in 4 countries.
Nikita SushentsevDepartment of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-4500-9714
Mary A McLeanDepartment of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
Anne Y WarrenDepartment of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Arnold J V BenjaminDepartment of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-2063-8258
Cara BrodieCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
Amy FraryDepartment of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-4373-3517
Andrew B GillDepartment of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
Julia JonesCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-9819-8091
Joshua D KaggieDepartment of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-6706-3442
Benjamin W LambDepartment of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID http://orcid.org/0000-0003-2220-893X
Matthew J LockeDepartment of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
Jodi L MillerCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-6870-204X
Ian G MillsPatrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
Andrew N PriestDepartment of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-9771-4290
Fraser J L RobbGE Healthcare, Aurora, OH, USA.
Nimish ShahDepartment of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Rolf F SchulteGE Healthcare, Munich, Germany.
Martin J GravesDepartment of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-4327-3052
Vincent J GnanapragasamDepartment of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Kevin M BrindleCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-3883-6287
Tristan Barrett *Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK. tb507@medschl.cam.ac.uk.
Ferdia A Gallagher *Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-4784-5230
University of Cambridge · GBCambridge University Hospitals NHS Foundation Trust · GBAurora Health Care · USQueen's University Belfast · GBSiemens Healthineers (Germany) · DE
Funding
Cancer Research UK 16628Cancer Research UK 17242Cancer Research UK 27150Cancer Research UK 28667Cancer Research UK C19212/A16628Cancer Research UK C19212/A27150Cancer Research UK C197/A17242Cancer Research UK C197/A29580Wellcome Trust
Abstract
Hyperpolarised magnetic resonance imaging (HP
Indexed as
AgedAged, 80 and overCohort StudiesEpithelial CellsGlycolysisHumansL-Lactate DehydrogenaseMagnetic Resonance ImagingMaleMiddle AgedMonocarboxylic Acid TransportersMuscle ProteinsProspective StudiesProstatic NeoplasmsPyruvic AcidStromal CellsL-Lactate DehydrogenaseMonocarboxylic Acid TransportersMuscle ProteinsPyruvic AcidSLC16A4 protein, human
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.